Lapatinib Completed Phase 2 Trials for Stage I Prostate Cancer / Stage IIA Prostate Cancer / Stage III Prostate Cancer / Recurrent Prostate Cancer / Stage IIB Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00103194Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer